RU-505 structure
|
Common Name | RU-505 | ||
|---|---|---|---|---|
| CAS Number | 1314206-29-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H32FN5O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RU-505RU-505 is an effective β-amyloid (Aβ)-fibrinogen interaction inhibitor with IC50s of 5.00 and 2.72 μM in fluorescence polarization (FP) and AlphaLISA assays, respectively. RU-505 is highly permeable to the BBB. RU-505 reduces cerebral amyloid angiopathy (CAA). RU-505 can be used for the research of Alzheimer’s disease (AD)[1]. |
| Name | N-Benzyl-N-[2-(dimethylamino)ethyl]-7-(4-fluorophenyl)-2-(2-methyl-2-propanyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | RU-505 is an effective β-amyloid (Aβ)-fibrinogen interaction inhibitor with IC50s of 5.00 and 2.72 μM in fluorescence polarization (FP) and AlphaLISA assays, respectively. RU-505 is highly permeable to the BBB. RU-505 reduces cerebral amyloid angiopathy (CAA). RU-505 can be used for the research of Alzheimer’s disease (AD)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C28H32FN5O |
|---|---|
| InChIKey | GMFHHCFJJZWFBW-UHFFFAOYSA-N |
| SMILES | CN(C)CCN(Cc1ccccc1)C(=O)c1cc(-c2ccc(F)cc2)n2nc(C(C)(C)C)cc2n1 |
| N-Benzyl-N-[2-(dimethylamino)ethyl]-7-(4-fluorophenyl)-2-(2-methyl-2-propanyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide |
| MFCD06620515 |
| Pyrazolo[1,5-a]pyrimidine-5-carboxamide, N-[2-(dimethylamino)ethyl]-2-(1,1-dimethylethyl)-7-(4-fluorophenyl)-N-(phenylmethyl)- |
| RU-505 |